According to the WHO Framework of indicators and targets for laboratory strengthening under the End TB Strategy, all sites that use WHO-recommended rapid diagnostics should be transmitting results electronically to clinicians and to information management systems using data connectivity solutions no later than 2020.
Furthermore, remote monitoring via data connectivity solutions should be used to monitor key performance indicators at all sites that use WHO recommended rapid diagnostics no later than 2020. - World Health Organization
Many worldwide healthcare programs rely on paper-based systems for managing patient diagnostics data and reporting. These systems can be time consuming, inefficient and susceptible to user error.
Connected diagnostics combined with a fully digitised paperless system will save time and improve quality, accuracy and immediacy of data.
CDP can be integrated with existing medical systems to enable centralised reporting. Selected data can be routed to and from external systems, such as tuberculosis surveillance monitors, hospital information systems and other third party tools.
A Connected Diagnostics Platform (CDP) for
1. The centralized aggregation, visualization and management of clinical test and device performance data from diagnostics;
2. The digitization of diagnostic test workflows and laboratory processes from patient registration, case history, examination and reporting of samples, as well reporting of quality metrics and key performance indicators.
In addition to displaying metrics regarding number of tests performed or indicators of error rates, CDP has been designed to accommodate common laboratory testing workflows and offers the full digitization of the paper based forms that are used i.e., for patient registration, sample referral and result reporting. The concept is that the entire end to end process of the diagnostic pathway is captured in a single system, that data is easily stored and accessed for informatics purposes, and that the results can be linked back to the patient so that decisions on their care can be taken.
Reliable and timely diagnostic test information is of paramount importance for the proper functioning of several components of the diagnostic and treatment cascade including patient management, epidemiologic surveillance, quality assurance, laboratory operations, and technical product support.
CDP links patient and episode data with test results generated both by connectable devices and un-connected devices (such as the microscope). The result is a single view of all testing activity at participating sites (and their associated labs) along with test results and treatment outcomes, all linked to the patient.
CDP can provide centralised reporting, as well as routing selected data into other external systems such as surveillance monitors. It is possible to establish a fully digital End to End process for patient testing and management by linking multiple, existing systems in CDP.
CDP is designed to be compatible with existing platforms and technologies used in clinics and labs throughout the world such as Nikshay and e-TB Manager.
Complete episodic history and diagnostic workflow
Integrate data from medical devices like Alere i, Alere Pima, Alere q & GeneXpert.
Digitise recording of tests such as microscopy, and line probe assay.
Collate and normalise data for efficient diagnosis, reporting, and monitoring of patients.
Registered in England & Wales. Company No. 5569666. Registered Office: St Marys House, Netherhampton, Salisbury, Wiltshire, SP2 8PU